On the public citation graph

Quaternary Structure, Substrate Selectivity and Inhibitor Design for SARS 3C-Like Proteinase

https://doi.org/10.2174/138161206779010396
0 signed · 38 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3623966openalex-extracted
Reaching New Lows? The Pandemic's Consequences for Electricity Markets
inferred← citeshttps://doi.org/10.1007/978-3-540-79086-0_1openalex-snapshot
Antiviral Strategies
inferred← citeshttps://doi.org/10.1007/978-3-642-03683-5openalex-snapshot
Molecular Biology of the SARS-Coronavirus
inferred← citeshttps://doi.org/10.1007/978-3-642-03683-5_8openalex-snapshot
Quaternary Structure of the SARS Coronavirus Main Protease
inferred← citeshttps://doi.org/10.1007/978-3-642-36260-6_3openalex-snapshot
SARS coronavirus main proteinase 3.4.22.69
inferred← citeshttps://doi.org/10.1016/j.antiviral.2008.05.005openalex-snapshot
High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery
inferred← citeshttps://doi.org/10.1016/j.antiviral.2011.08.001openalex-snapshot
Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
inferred← citeshttps://doi.org/10.1016/j.bmc.2008.01.011openalex-snapshot
Structure-based virtual screening against SARS-3CLpro to identify novel non-peptidic hits
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112711openalex-snapshot
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020
inferred← citeshttps://doi.org/10.1016/j.joim.2020.02.005openalex-snapshot
In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus
inferred← citeshttps://doi.org/10.1016/j.tmaid.2020.101810openalex-snapshot
Traditional Chinese Herbal Medication for corona-virus 2019
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c01229openalex-snapshot
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective
inferred← citeshttps://doi.org/10.1021/acs.jpcb.4c01938openalex-snapshot
Competitive Interaction of the SGFRKMAF Peptide with 3CLpro Dimerization Intermediates: A Brownian Dynamics Investigation
inferred← citeshttps://doi.org/10.1021/bi0621415openalex-snapshot
Substrate Specificity Profiling and Identification of a New Class of Inhibitor for the Major Protease of the SARS Coronavirus,
inferred← citeshttps://doi.org/10.1021/bi1002585openalex-snapshot
Mutation of Asn28 Disrupts the Dimerization and Enzymatic Activity of SARS 3CL pro ,
inferred← citeshttps://doi.org/10.1021/bi801034fopenalex-snapshot
Substrate Inhibition Kinetic Model for West Nile Virus NS2B-NS3 Protease
inferred← citeshttps://doi.org/10.1021/ci1004916openalex-snapshot
Inhibitors of SARS-3CL pro : Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation Studies
inferred← citeshttps://doi.org/10.1021/jm301580nopenalex-snapshot
Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease
inferred← citeshttps://doi.org/10.1038/nrmicro2090openalex-snapshot
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
inferred← citeshttps://doi.org/10.1039/d2me00098aopenalex-snapshot
Design of peptide-based coronavirus inhibitors that target disruption of 3CLpro protease self-association
inferred← citeshttps://doi.org/10.1074/jbc.m109.095851openalex-snapshot
Maturation Mechanism of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-like Proteinase
inferred← citeshttps://doi.org/10.1074/jbc.m115.651463openalex-snapshot
Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro)
inferred← citeshttps://doi.org/10.1080/07391102.2021.1996462openalex-snapshot
Disruption of 3CLpro protease self-association by short peptides as a potential route to broad spectrum coronavirus inhibitors
inferred← citeshttps://doi.org/10.1107/s2052252521010113openalex-snapshot
Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography
inferred← citeshttps://doi.org/10.1111/cbdd.13914openalex-snapshot
Fragment‐based in silico design of SARS‐CoV‐2 main protease inhibitors
inferred← citeshttps://doi.org/10.1111/j.1747-0285.2008.00679.xopenalex-snapshot
Development of Broad‐Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CLpro
inferred← citeshttps://doi.org/10.1128/9781555815790.ch5openalex-snapshot
Coronavirus Replicative Proteins
inferred← citeshttps://doi.org/10.1360/ssc-2020-0145openalex-snapshot
Advances in enzymatic activity regulation mechanism and inhibitor discovery of coronavirus 3C-like protease
inferred← citeshttps://doi.org/10.21203/rs.3.rs-764141/v1openalex-snapshot
Emergency Available Drugs in Markets to Treat COVID-19
inferred← citeshttps://doi.org/10.26434/chemrxiv.12090426openalex-snapshot
Computational Evaluation of the COVID-19 3c-like Protease Inhibition Mechanism, and Drug Repurposing Screening
inferred← citeshttps://doi.org/10.26434/chemrxiv.12090426.v1openalex-snapshot
Computational Evaluation of the COVID-19 3c-like Protease Inhibition Mechanism, and Drug Repurposing Screening
inferred← citeshttps://doi.org/10.26434/chemrxiv.13550246openalex-snapshot
Extensive Crystallographic Fragment-Based Approach to Design SARS CoV2 3CLpro Main Protease Inhibitors and Related Metadata
inferred← citeshttps://doi.org/10.26434/chemrxiv.13550246.v1openalex-snapshot
Extensive Crystallographic Fragment-Based Approach to Design SARS CoV2 3CLpro Main Protease Inhibitors and Related Metadata
inferred← citeshttps://doi.org/10.31254/jahm.2020.6310openalex-snapshot
In-silico screening of active molecules from medicinal plant resources for controlling SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.32657/10356/41875openalex-snapshot
Development of SARS-COV therapeutics using quaternary protein mimetics
inferred← citeshttps://doi.org/10.33140/jgebr.4.03.13openalex-snapshot
Molecular Docking Analyses of Phytochemicals from African Herbal Plants Exhibit Inhibitory Activity against Therapeutic Targets of Sars-COV-2
inferred← citeshttps://doi.org/10.34172/ps.2021.11openalex-snapshot
Natural products as inhibitors of COVID-19 main protease–A virtual screening by molecular docking
inferred← citeshttps://doi.org/10.9734/arrb/2020/v35i830260openalex-snapshot
Screening of Common Herbal Medicines as Promising Direct Inhibitors of Sars-Cov-2 in Silico
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.